{ "items": [ "\n\n
\n \n\n \n \n \n \n Botnar\n \n \n\n \n\n\n
\n \n \n \nOur work focuses on Ageing and Longevity mechanisms, identifying and characterising factors which control lifespan to better understand and treat age-related disorders.
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n\n \n\n\n
\n \n \n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n \n \n CSM\n \n \n \n \n Statistics and epidemiology\n \n \n\n \n\n\n
\n \n \n \nObservational Research - \r\nPharmaco-epidemiology - \r\nMethods Research
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n\n \n\n\n
\n \n \n \nWe are interested in studying the burden of musculoskeletal conditions to the NHS, other national healthcare systems, and to the whole society.
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n\n \n\n\n
\n \n \n \nWe focus on research that can directly improve the outcome for patients who undergo surgery for degenerative osteoarthritis of the knee.
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n \n \n Hip\n \n \n\n \n\n\n
\n \n \n \nOur research focuses on hip osteoarthritis, from identifying its causes to developing new surgery techniques for the condition.
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n\n \n\n\n
\n \n \n \nWe are deeply involved in research, teaching and training to strengthen surgical care and training capacity in Africa.
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n\n \n\n\n
\n \n \n \nOver the last ten years we have focused our research on developing better approaches to the diagnosis of vasculitis.
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n\n \n\n\n
\n \n \n \nOur main research goal is to understand the molecular mechanisms causing inflammation, particularly in Ankylosing Spondylitis and other forms of inflammatory arthritis including Psoriatic Arthritis, and to translate this understanding into new patient therapy.
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n\n \n\n\n
\n \n \n \nThe research in our group focuses on target identification and validation in a spectrum of human diseases including benign and malignant soft tissue tumours or hematological malignancies affecting the skeleton such as multiple myeloma, and inflammatory conditions including endometriosis, cardiovascular disease, or autoimmune diseases.
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n\n \n\n\n
\n \n \n \nWe aim to identify the mechanisms contributing to bone disease caused by cancer and develop new treatments for these conditions.
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n\n \n\n\n
\n \n \n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n\n \n\n\n
\n \n \n \nWe aim to be a centre of excellence for the design and management of surgical trials, focussing on answering important health questions in the UK and worldwide.
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n \n \n Kennedy\n \n \n\n \n\n\n
\n \n \n \nEstablished in 2013, the Centre for Osteoarthritis Pathogenesis Versus Arthritis aims to develop new treatments for this disabling condition, improving healthcare and transforming people's lives.
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n\n \n\n\n
\n \n \n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n\n \n\n\n
\n \n \n \nOrthopaedic engineering is a highly active and fascinating area of research, which has the potential to directly benefit patient healthcare.
\n \n\n \n \n\n \n\n \n \n \n \n Botnar\n \n \n\n \n\n\n
\n \n \n \nOur group is working on a range of projects to develop, evaluate and introduce modern therapy technologies in the National Health Service. Our work focuses on people who have life changing musculoskeletal injury and / or substantial chronic health conditions.
\n \n\n \n \n